Acute bacterial meningitis: Time for a better outcome

Intensive Care Medicine

Volumn 29, Issue 11, 2003, Pages 1868-1870

  Zimmerli, Werner ^a  

^a KANTONSSPITAL LIESTAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID; MATRIX METALLOPROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

APOPTOSIS; BACTERIAL MENINGITIS; BRAIN BLOOD FLOW; CLINICAL TRIAL; EDITORIAL; FATALITY; HAEMOPHILUS INFLUENZAE; HIPPOCAMPUS; HUMAN; LISTERIA MONOCYTOGENES; NEISSERIA MENINGITIDIS; OXIDATION; PATHOGENESIS; PROGNOSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; CRITICAL CARE; DEXAMETHASONE; HUMANS; MENINGITIS, BACTERIAL; NEEDS ASSESSMENT; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; VACCINATION;

EID: 0344394243     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1934-5     Document Type: Editorial

References (14)

1. Finland M, Barnes MW (1977) Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. J Infect Dis 136:400-415
2. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21-28
3. Aronin SI, Peduzzi P, Quagliarello VJ (1998) Community-acquired bacterial meningitis: risk stratification, adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129:862-869
4. Schlech WF III, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV (1985) Bacterial meningitis in the Unites States 1978 through 1981. JAMA 253:1749-1754
5. Sigurdardóttir B, Björnsson OM, Jonsdóttir KE, Erlendsdóttir H, Gudmundsson S (1997) Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 157:425-430
6. Hussein AS, Shafran SD (2000) Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 79:360-368
7. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Bradley A, Perkins BA for the Active Surveillance Team (1997) Bacterial meningitis in the United States in 1995. N Engl J Med 337:970-976
8. Meli DN, Christen S, Leib SL, Täuber MG (2002) Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis 15:253-257
9. Brandtzaeg P, Deuren M (2002) Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr Opin Infect Dis 15:247-252
10. Echchannaoui H, Frei K, Schnell Ch, Leib SL, Zimmerli W, Landmann R (2002) Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186:798-806
11. Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Täuber MG, Leppert D (2001) Inhibition of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124:1734-1742
12. Loeffler JM, Ringer R, Hablützel M, Täuber MG, Leib SL (2001) The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis 183:247-252
13. Gans J, Beek D (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347:1549-1556
14. Flores-Cordero JM, Amaya-Villar R, Rincón-Ferrari MD, Leal-Noval SR, Garnacho-Montero J, Llanos-Rodriguez AC, Murillo-Cabezas F (2003) Acute community-acquired bacterial meningitis in adults admitted to the ICU: clinical manifestations, management and prognostic factors. Intensive Care Med (http://dx.doi.org/10.1007/ s00134-003-1935-4)